Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

5FTO

Crystal structure of the ALK kinase domain in complex with Entrectinib

Summary for 5FTO
Entry DOI10.2210/pdb5fto/pdb
Related5FTQ
DescriptorALK TYROSINE KINASE RECEPTOR, Entrectinib (3 entities in total)
Functional Keywordstransferase, kinase inhibitors, cancer, drug discovery, alk, trk, ros1, anaplastic large cell lymphoma (alcl), non small cell large cancer (nsclc), neuroblastoma, colorectal cancer (crc)
Biological sourceHOMO SAPIENS (HUMAN)
Cellular locationCell membrane ; Single-pass type I membrane protein : Q9UM73
Total number of polymer chains1
Total formula weight35895.25
Authors
Primary citationMenichincheri, M.,Ardini, E.,Magnaghi, P.,Avanzi, N.,Banfi, P.,Bossi, R.T.,Buffa, L.,Canevari, G.,Ceriani, L.,Colombo, M.,Corti, L.,Donati, D.,Fasolini, M.,Felder, E.R.,Fiorelli, C.,Fiorentini, F.,Galvani, A.,Isacchi, A.,Borgia, A.L.,Marchionni, C.,Nesi, M.,Orrenius, C.,Panzeri, A.,Pesenti, E.,Rusconi, L.,Saccardo, B.M.,Vanotti, E.,Perrone, E.,Orsini, P.
Discovery of Entrectinib: A New 3-Aminoindazole as a Potent Anaplastic Lymphoma Kinase (Alk), C-Ros Oncogene 1 Kinase (Ros1), and Pan-Tropomyosin Receptor Kinases (Pan-Trks) Inhibitor.
J.Med.Chem., 59:3392-, 2016
Cited by
PubMed: 27003761
DOI: 10.1021/ACS.JMEDCHEM.6B00064
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.22 Å)
Structure validation

218196

PDB entries from 2024-04-10

PDB statisticsPDBj update infoContact PDBjnumon